Related Experiment Video
Updated: Oct 18, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
The intra-aortic cannula pump: A novel assist device for the acutely failing heart
R Sharony1, E Porat, Y Nishimura
1Department of Cardiothoracic Surgery, Carmel Medical Center, Rappaport Institute, Faculty of Medicine, Technion-IIT, Haifa, Israel. sharonyr@tx.technion.ac.il
Insights
The intra-aortic cannula pump effectively supports acutely failing hearts by improving cardiac output and reducing left atrial pressure. This new device shows promise for treating moderate to severe heart failure.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Critical Care
Background:
- Acute heart failure presents a critical challenge in cardiovascular medicine.
- Existing treatments for acute heart failure have limitations.
- Novel intracardiac support systems are needed to improve patient outcomes.
Purpose of the Study:
- To evaluate the hemodynamic performance of a novel intra-aortic cannula pump.
- To assess the efficacy of this device in supporting the acutely failing heart.
- To analyze its impact on key hemodynamic parameters in different stages of heart failure.
Main Methods:
- A 24F intra-aortic cannula pump was tested in a sheep model (n=16).
- Heart failure was induced using microsphere injection into the left anterior descending coronary artery.
- Hemodynamic parameters were measured in nonfailing, moderately failing, and severely failing hearts.
Main Results:
- Cannula insertion was technically feasible in all subjects.
- The device significantly increased cardiac output in moderately and severely failing hearts (p < .001).
- Left atrial pressure decreased, and systemic blood pressure increased in severe heart failure (p < .001).
Conclusions:
- The intra-aortic cannula pump demonstrates significant hemodynamic benefits in moderate and severe acute heart failure.
- This device represents a promising new therapeutic option for acute heart failure.
- Further clinical investigation is warranted to confirm these findings in human patients.
Objective:
The intra-aortic cannula pump is a catheter pump designed to support the acutely failing heart. It expels blood from the left ventricle into the ascending aorta in a pulsatile flow pattern. The aim of the study was to analyze the hemodynamic performance of this new intracardiac support system in acute heart failure.
Methods:
A 24F cannula was studied in a series of 16 sheep. Hemodynamic changes were assessed in the nonfailing, the moderately failing, and the severely failing heart. Heart failure was induced by an injection of microspheres into the left anterior descending coronary artery. The cannula was inserted through the aortic arch and introduced through the aortic valve into the left ventricle.
Results:
Cannula insertion was feasible in all animals. Flow through the intra-aortic cannula flow was increased to a maximum of 3 L/min. No hemodynamic changes were observed in the nonfailing heart. A significant increase in cardiac output was observed in the moderately and severely reduced left ventricle (2.67 +/- 0.7 L to 3.51 +/- 0.83 L; P =.001; and 1.18 +/- 0.77 L to 2.43 +/- 0.44 L; P =.001, respectively). A drop in left atrial pressure was achieved in moderate and severe heart failure (14.1 +/- 5.93 mm Hg to 9.71 +/- 2.63 mm Hg; P =.0001; and 23 +/- 7.16 mm Hg to 11.2 +/- 2.55 mm Hg; P = 0.0001, respectively). Systolic and diastolic systemic blood pressures increased in the severely failing heart (57.3 +/- 12.8 mm Hg to 75.4 +/- 11.2 mm Hg; P =.0001; and 35.6 +/- 8.2 mm Hg to 60 +/- 14.3 mm Hg; P =.0006, respectively).
Conclusions:
Hemodynamic data demonstrate the beneficial effects of the intra-aortic cannula pump in moderate and severe heart failure. The intra-aortic cannula pump represents a new modality for the treatment of acute heart failure.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy

